SiRNA therapy for liver disease (EnnovaBio )

肝脏疾病siRNA疗法（轶诺药业）

Report date: 2025/05/09 10:54:29
NME

Base Information

Drug NameSiRNA therapy for liver disease (EnnovaBio )
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHepatitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai EnnovaBio Pharmaceuticals Co LtdDarui Biomedical Technology (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai EnnovaBio Pharmaceuticals Co LtdDarui Biomedical Technology (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A